Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for the use of low-dose immune modulators transiently for treating patients undergoing protein replacement therapy

Methods for the use of low-dose immune modulators transiently for treating patients undergoing protein replacement therapy

US Patent 11944628 · Granted Apr 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for treating and/or preventing glycogen storage disease2025
Method of reducing titers of antibodies specific for a therapeutic agent2025
Methods and compositions for the treatment of cytoplasmic glycogen storage disor2024
Method of treating glycogen storage disease type VI2022
Method of reducing titers of antibodies specific for a therapeutic agent2020
Method of treating glycogen storage disease type IX using acid alpha-glucosidase2020
Method of reducing titers of antibodies specific for a therapeutic agent2018
Methods for treating glycogen storage disease type IV usng lysosomal acid alpha-2017
Method of reducing titers of antibodies specific for a therapeutic agent2017
Method of treating glycogen storage disease type III with human acid α-glucosida2015
Method of reducing titers of antibodies specific for a therapeutic agent2014